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coronary angingraphy performed from 12/93 to 8/94 at our institution. The 
Inc ide~ of 25% rise in serum creatinine was 145/1000 cases and the 
incidence of renal failure requiring dialysis was 8/10~0 cases. The cutoff 
dose of contrast below which there were no dialysis cases was 100 ml. 
No patient with a baseline calculated creatinine clearance (CrCI, Cockcroft- 
Gault method) above 47 ml/min developed renal failure requiring dialysis. 
Multivariate analyses revealed baseline CrCI (OR = 0.85, 95% CI 0.80-0.90, 
p < 0.00001), diabetes (OR = 5.12, 95% CI 1.37-19.22, p = 0.16), and 
contrast dose (OR = 1.006, 95% CI 0.999-1.011, p = 0.053) as predictors of 
dialysis. The significant, independent relationships between severity of renal 
failure and case-mortality rate are shown below. 
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Conclusions: 1) The rate of renal failure requiting dialysis after coronary 
intervention is 0.8%. 2) A minimum CrCI of 47 mVml or a maximal contrast 
dosage of 100 mi may be thresholds beyond which eedous renal failure 
can occur. 3) Baseline creatinine clearance, diabetes, and contrast dose 
are important independent predictors of contrast nephropathy. 4) Contrast 
nephropathy, especially in those cases requiring dialysis, is strongly associ- 
ated with high (33.3%) in-hospital mortality. 
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~ 7  High-Pressure Inflations Do Not Insure 'Adequate' 
Stent Deployment: E~tidence From Intravascular 
Ultrasound 
Anthony C. De Franco, E. Murat Tuzcu, Khaled M. Ziada, Nirav Shah, 
Seilash Babu, A. Michael Lincoff, Russell Raymond, Patrick L. Whitlow, 
Stephen G. Ellis, Steven E. Nissen. Cleveland Clinic OH 
Background: Intmvascular ultrasound cdtsria for adequate stent deployment 
require a minimum cross-sectional area, typically > 70-80%o of an adjacent 
reference site. However, the morphology and procedural factors associated 
with failure to fully expand are uncertain. 
Methods: A core laboratory measured lumen diameter and area, plaque 
thickness and area, as well as percent area reduction. Inadequate expansion 
was defined as any segment < 70% of the area of the mean proximal and 
distal reference segments by ultrasound. 
Results: Of 74 stents, 13 (17.5%) had inadequate xpansion at a time when 
the angio~lram suggested procedural completion. There were no significant 
differences between the two groups in anglagraphic vessel size (mean, 3.12 
vs 3,23 ram), maximum balloon pressure (mean, 17,3 vs. 16.4 atm), inflation 
time, pre-procedural lesion severity, or ACC/AHA lesion score. Patients with 
inadequate deployment were treated with additional inflations, wadadn, or 
both). 
Post-stent Measurements Adequate Inadequate p 
Ultrasound Reference Size (ram) 3.34 3.50 0.05 
Mean Plaque Thickness (mm) 0.69 0.g5 0.004 
Anglo Final Stenosis (%) -2.3% +4.7% 0.03 
Ultrasound Area Reduction (%) 53.5 64.1 0.003 
Anglo Baltoon/Re terence Ratio 1.17 1.13 NS 
Ultrasound Balloon/Reference Ratio 1.15 1.02 0.003 
C¢nclusions: Despite "high-pressure" stent technique, 17% fail to achieve 
a typical cdtedon for adequate expansion, usually in segments with a heavy 
plaque burden and/or a low balloon-to-vessel size ratio calculated by ultra- 
sound (but not angiography). Thus: 1) Angiography alone may be insufficient 
to determine which patients can forego warfarin, 2) Ultrasound identifies pa- 
tients who may benefit from pre-stent debulking and/or additional inflations 
with a larger balloon. 
2:15 
Can Quantitative Coronary  Analysis Replace 
Inlravascular Ultrasound to As=,o~ Optimal Stent 
Deployment? 
Luc eiloOeau, Serge Doucet, Gilles CatS, dean-Claude Tardif, Raoul 
Bonan Olivier, F. Bertrand. Montreal Heart Institute, Montreal, Canada 
The accepted IVUS criteria of optimal stent deployment are: complete ap- 
position, symmeW index > 0.7, and minimum inner stent area > than the 
distal reference area as well as > than 96=/0 average reference area. To 
define angiographic critsda of optimal stent deployment we reviewed an- 
giograms of 35 stsnts implanted under IVUS guidance (HP ~ 30 mHz). All 
angiograms were analysed by quantitative cumnary analysis (CMS system). 
The deployment of the stents analysed was defined as optimal (n = 25) or 
non optimal (N = 27) according to the above mentioned IVUS criteria. Using 
the best angiagraphic view, the diameter of the proximal and distal reference 
segments were measured. The stent measurements included the minimum, 
maximum and mean inner diameters. The ratios between the inner stent di- 
ametere and the mean proximal, distal and interpolated reference diameters 
were calculated. 
! 
Receiver operating characteristic (ROC) curves were used to evaluate 
the performance of these d~emnt ratios. None of the tested angingraphtc 
parameters and ratios could predict adequate stent deployment. Thus IVUS 
still remains the most discriminating tool to assess stent deployment. 
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~- ' ]  Is Quantitative Angiography a Surrogate of 
Intrevascelar Ultrasound for Guidance of Stem 
Deployment? A Compar ison With 3-D Quanti tat ive 
Reconstruction of  Intracoronary Ultrasound 
Francesco Prati, Cado Di Mado, Robert Git, Edoardo Camenzind, 
Clemens yon eirgelen, Eiine Van Swijndregt, Patrick W. Serruys. 
Thoraxcenter, Erasmus University, Rotterdam, The Netherlands 
Aim of this study was to assess the usefulness of quantitative coronary an- 
gingraphy for the evaluation of optimal stent expansion, confirmed with a 
new on-line system of three-dimensional reconstruction of intravescular ul- 
basound (IVUS). Seventy 5tsnts (31 Palmaz-Schalz, 22 Wallstent, 7 Cordis, 
6 Micro-stent, 2 Gianturcu-Roubin, 2 Multi-link) were imaged in 49 patients 
with 3-D IVUS. IVUS assessment was performed after achievement of an 
optimal on-line quantitative cumnary angiography (QCA) result, defined as 
negative percent diameter stenosis (stent MLD/user defined reference diam- 
eter). QCA percentage diameter stenosis was also calculated off-line with 
a "stent analysis" approach, limited to the stented part of the vessel sng- 
menL as the ratio stent MLD/interpolated reference diameter. IVUS images 
of stents and adjacent proximal and distal reference segments were acquired 
using a motorized pull-bank at a constant speed (1 ram/s) and immediately 
processed in the catheterization laboratory using an automated contour de- 
tection algorithm based on acoustic quantification. IVUS criteria indicative of 
optimal stent expansion were: 1 ) complete appos~on of stent struts to vessel 
wall; 2) minimal stent lumen area greater or equal to 80% of the average 
lumen area of the proximal and distal reference segments. 
Results: Comparison of QCA and 3-D IVUS measurements are reported 
in the table. 
On-line QCA Off -Itne QCA 3-D IVUS 
Vessel analysis Intrestent a alysis 
Stent MLD 2.7 =l: 0.4 2.7 4. 0.4* 3.0 4. 0.5 
% Area Stenosis -5.1 4. 8.4%* 9.5 4. 5.0%* 24 :t: 6.1% 
Legend. MLD = Minimal lumen diameter, *p < 0.01 
3-D IVUS cfitefla of adequate stent expansion were achieved only in 30 
out of 70 stsnts (43%). By using a QCA "stent analysis" approach it was 
found that a 10% diameter stenosis cut-off value revealed adequate stent 
expansion with high specificity (86%). Conclusions: 3-D IVUS criteda of 
adequate stent expansion are achieved only in 43% of patients despite the 
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application of aggressive strategies of stsnt deployment leading to optimal 
results with quantitative angiogrepby. The clinical benefit of an IVUS guided 
approach of stant deployment and of a lower cost strategy based on QCA 
guidance shoutd be compared in prospective randomized studies. 
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~ '~ ls  There Benefit From Intravsscular Ultrasound a 
When High-Pressure Stent Expansion Is Routinely 
Perform,~l Prior to Ultrasound Imaging? 
Stsven L. Goldberg, Patrick Hall, Shigeru Nakamura, Luigi Malelfo, 
Yaron AImagor, Jonathan Tobis, Antonio Colombo. Contro Coors 
Columbus, Milan, Italy, Harbor-UCLA Medical Center, Torrance, CA 
When high-pressure balloon inflations (HPBrs) are routinely performed ur- 
ing stent deployment, itis unclear if intravascular ultrasound (IVUS) imaging, 
adds any additional benefit. A rotmspective analysis was performed of 305 
consecutive lesions slanted with IVUS guidance after HPBrs. IVUS criteria 
for optimal slanting was: 1 ) Intrastent cross-sectional rea (CSA) was > dis- 
tal "normal" lumen CSA, and 2) No potential f ow-limiting lesions proximal or 
distal to the stented segment ware seen. "IVUS improvement" was defined 
as 1) > 25% increase in intrastent CSA when further inflations were made 
due to findings from IVUS, or 2) ,stenting of a potentially flow-flmifing lesion 
proximal or distal to the stented segment, identified by IVUS. Results: The 
mean inflation pressure prior to IVUS was 14.7 4- 3.2 arm. Only 47% of 
stectsd lesions were identified as optimal by the first IVUS imaging. CSA 
increased from 6.94 4- 2.02 mrn ~ at the time of the first IVUS imaging to 8.04 
4- 1.93 mme when finished (p < 0.001). "IVUS improvement" was seen in 
39%: 26% (8,3/315) with an increase in CSA >_ 25% and 16% (51/315) with 
additional slanting for disease identified by IVUS as potentially flow-limiting. 
Conclusion: IVUS imaging after high-pressure bell~on inflation inside 
slants demonstrates optimal results in only 47% of lesions. WUS-guidance 
leads to significant improvements in anatomic appearance 39% of the time. 
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~5-1  IS Intravascular Necessary Ultrasound Guidance 
When Using the Johnson-Johnson Slant Without 
Anticeagutation 
Christopher M. Goods, Larry S. Dean, Ming W. I_iu, Khaled F. AI-Shalbi, 
Srirem S. lyero J. Michael Parks, Ronald J, Sutor, Gary S. Roubin. University 
of Alabama at Birmingham, Birmingl;am, AL 
Between 9/94 and 8/95, 95 patients (pts) had Johnson-Johnson stents ira. 
pianted in native coronary arteries. Eighty two pts receiving 114 stents were 
s,~!scted to receive antiplatelet therapy only, 73 pts were treated with Aspirin 
and "riclopidine and 9 lots with Aspirin alone. Patients were selected for an- 
flplaletet therapy based on angiogmphic riteria, i.e. no significant residual 
stanosls, uncovered issection, tilling defect, or outflow obstruction following 
high pressure balloon inflations. Intravascular ultrasound was not used to 
assist in this process. Indications for stenting were suboptimal rosuifs (25 
lots), lesion restenosis (7 tots), ostlal lesions (26 pts) and de-novo stenting 
(24 pts). The vessel slanted was the LAD (31 pts), RCA (45 pts), LCX (6 pts) 
and LM (6 pts). Forty four pts received biliary stents. The average stent size 
was 3.49 4- 0.36 ram, range 3-5 ram. 
Results: Thhly day follow up was available in all eligible pts (n = 77). No 
pt had slant thrombosis. There were no deaths or Q-wave myocardial infarc- 
tions and no pt required bypass surgery. Non-Q-wave myocardial infarction 
occurred in 2 nts (2.4%). Bleeding requiting blood transfusion occurred In 
one pt (1.2%/. 
Conclusion: In this group of pts, stent thrombosis did not occur and the 
incidence of comorbldify was low. Intravascular ultrasound increases pro- 
cedural time and cost and appears to be unnecessary before removing 
anticoagulalion from post stsnflng protocols. 
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~ An~lography Versus Intravsscular 
Ultrasound-Dirscted Stent Placement 
Robert J. Russo, Paul S. Talrstein, for the A.V.I.D. Investigators. Scripps 
Clinic and Research Foundation, La Jcila, CA 
In the A.V.I.D. [Angiography vs. Inlravascular Ultrasound (IVUS)-Dlrected 
Stent Placement] muificenter trial, patient outcome after IVUS-directed stent 
placement is compared to stent placement directed by angiogrspby. After 
an optimal angiographic result is obtained, patients are randomized to an- 
giography or tVUS-directed therapy. In the angiogrephy arm, blinded IVUS is 
performed and the patient discharged on aspirin 325 rag/day and ticlopidine 
500 rag/day for 4 weeks. In the tVUS-directed arm, patients who fail IVUS 
crltsri:-'; are treated with larger balloons. Patients who fulfill IVUS criteria (< 
10% stenosie and full slant apposition) am discharged on aspirin and tiolopl- 
dine. Patients who fail IVUS or anglogrephlc riteria receive enoxapadn (70 
mg/day) for 2 weeks in addition to aspirin and ticlopidine. Endpoints include 
stent thrombosis, death, MI, urgent bypass or repeat intervention within 30 
days and target lesion revascularlzation at6 and 12 months. To date, 163 pa- 
tients have been randomized and 136 am eligible for 30-day follow-up. Mean 
length of stay is 1.88 days :1:1.44 in the IVUS group and 1.46 days :1:0.96 in 
the angingraphy group (p = ns). In the IVUS group, 33% of patients required 
additional therapy to fulfill IVUS criteria. At 30-day follow-up, 2 pts (2.9%) in 
the angiography group and 1 (1.5%) in the IVUS group experienced acute 
in-hospital stsnt thrombosis (p ,, ns); 1 pt (1.4%) in the anglography group 
died and none in either group required urgent bypass or repeat intervention. 
Conclusion: To date, IVUS-directed stent implantation has not influenced 
the 30-day clinical event rate; 6- and 12-roonth follow-up is pending. 
Pathophyaiol0gic Mechanisms of Unstable 
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~9~-]  Macrophages, Smooth Muscle Cells and Tissue 
Factor in Unstable Angina: Implications for Cell 
Mediated Thrambogenicity in Acute Coronary 
Syndromes 
Pedro R. Moreno, MD, Victor H. Bemardi, MD, Julio Lopoz-Cualtsr, MD, Igor 
R Palaclos, MD, Herman K. Gold, MD, Yale Nemerson, MD, Valantin Fuster, 
MD, PhD, John T. Fallon, MD, PhD. Massachusetts General Hospital, 
Boston, MA; Harvard Medical School, Boston, MA; Cardiovescular Institute, 
New York, New York, Mount Sinai School of Medicine, New York, New York 
Macrophagas (MACS) and smooth muscle cells (SMC) have been implicated 
in the pathophvsiology of acute coronary syndromes. The lipid-rich atherema- 
tous gruel is a potent hmmboganio subetrate and macrophage xpression of 
tissue factor (1"[=), mw be responsible for its thrombogeniclty. SMC may be 
involved in the thrombotic response of lesions without plaque n~ture. This 
study was designed to identify cellular correlations ol TF content in coronary 
plaque tissue from patients with unstable angina. Computerized planimetry 
was used for systematic quantification of tissue charactedstiss of 50 direc- 
tional coronary atherectomy specimens from patients with unstable angina. 
Total and segmental areas (mt~) were identified with trichrome staining and 
Included coitagon-fich sclerotic tissue, hyperoellular tissue, fibroceflular tis- 
sue, atherornstous gruel and thrombus. MACS, SMC and TF were identified 
with monoclonal antibody (KP-1), alpha actin and polyclonal TF antibody re- 
spectively. A total of 1207 pieces of tissue were quantified. Multiple stepwise 
regression analysis showed that coronary TF content could be predicted 
reliably (r = 0.83, P < 0.0001) on the basis of MACS and SMC plaque areas. 
Colocalization analysis in the atherometous gruel demonstrated a strong 
relationship between TF content and MACS areas (r ,- 0.98, P < 0.0001). 
These results show that TF content in coronary plaque tissue correlated 
with areas of MACS and SMC. Furthermore, TF content in the alheromatous 
gruel is probably mediated by MACS suggesting a call-mediated thrombo- 
genicify in patients with acute cerenary syndromes. 
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~ 2 7  Fibrinogen and C-rosstlve Protein Are Strong 
Prognostic Markers in Unstable Coronary Artery 
Disease 
Henrik Toss, Agoeta Slegbohn 1, tars Wallentln. Dept. of Cardiology, 
Uppsala, Sweden; 1 Clin. Chemistry, University Hospital, Uppsala, Sweden 
A total of 546 patients were included in a randomized, placebo controlled, 
double blind, multicantsr study evaluating the effect of daltspadn, a low 
molecular weight hsparin, in unstable coronmy artery disease, i.e. unstable 
angina bectoris or non-Q-wave AMI. Patients with newly developed or in- 
creased angina pectoris during the last two months, and with latest episode 
CRP mg/L Fib. g/L 
< 7 > 7 p < 3.58 > 3.58 p 
(n = 269) (n - 273) (n = 275) (n = 271 )
d,~0 Death 0.7 3.7 < 0.05 0 4.4 < 0.001 
% +AMI 6.3 10.3 0.1 5.8 11.1 < 0.05 
d 150 Death 2.2 8.1 < 0.01 2.9 7.4 < 0.05 
% +AMI 11.9 18.7 < 0.05 11.3 19,6 < 0.01 
